1 completed, 1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Neurognostics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis Glatiramer acetate, (Copaxone®), IFN-β-1a, (Avonex®) - Relapsing-Remitting Multiple Sclerosis | Terminated | Neurognostics | 48 | 2006-09-01 | 2007-12-05 | |
| A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties Donepezil HCI (drug) - Relapsing-Remitting Multiple Sclerosis | Phase 4 | Completed | Neurognostics | 26 | 2004-09-01 | 2007-10-16 |
Multiple Sclerosis (2) · Multiple Sclerosis, Relapsing-Remitting (2) · Memory Disorders (1)
Glatiramer Acetate (1) · Interferon beta-1a (1) · Pharmaceutical Preparations (1)
United States (2)
Catherine L Elsinger, PhD (1) · Safwan Jaradeh, MD (1) · Stephen M Rao, PhD (1)